首页> 外文OA文献 >Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

【2h】

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

机译：如所示，在早期乳腺癌患者中进行了剂量密集的序贯辅助化疗，随后是曲妥珠单抗治疗了一年：希腊合作肿瘤小组随机III期临床试验的5年中位随访首次报道

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
George Fountzilas; Urania Dafni; Christos Papadimitriou; Eleni Timotheadou; Helen Gogas; Anastasia G Eleftheraki; Ioannis Xanthakis; Christos Christodoulou; Angelos Koutras; Christos N Papandreou; Pavlos Papakostas; Spyros Miliaras; Christos Markopoulos; Constantine Dimitrakakis; Panagiotis Korantzopoulos; Charisios Karanikiotis; Dimitrios Bafaloukos; Paris Kosmidis; Epaminontas Samantas; Ioannis Varthalitis; Nicholas Pavlidis; Dimitrios Pectasides; Meletios-Athanassios Dimopoulos;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial [J] . George Fountzilas, Urania Dafni, Christos Papadimitriou, BMC Cancer . 2014,第1期

机译：如所示，在早期乳腺癌患者中进行剂量密集的序贯辅助化疗，然后是曲妥珠单抗治疗一年：希腊合作肿瘤小组随机III期临床试验的5年中位随访首次报道
2. Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00. [J] . Fountzilas G, Dafni U, Gogas H, Annals of oncology: official journal of the European Society for Medical Oncology . 2008,第5期

机译：高危乳腺癌患者术后用表柔比星，紫杉醇和CMF进行剂量密集的序贯化疗：希腊合作肿瘤小组的III期随机临床试验HE 10/00的安全性分析。
3. Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00 [J] . G. Fountzilas1 U. Dafni2 H. Gogas3 H. Linardou4 H. P. Kalofonos5 E. Briasoulis6 D. Pectasides7 E. Samantas8 D. Bafaloukos4 G. P. Stathopoulos9 M. Karina1 C. Papadimitriou10 D. Skarlos9 N. Pisanidis11 P. Papakostas12 C. Markopoulos3 E. Tzorakoeleftherakis5 K. Dimitrakakis10 P. Makrantonakis13 N. Xiros7 A. Polichronis14 I. Varthalitis15 C. Karanikiotis16 and A. M. Dimopoulos10 Annals of Oncology . 2008,第5期

机译：高危乳腺癌患者术后用表柔比星，紫杉醇和CMF进行剂量密集的序贯化疗：希腊合作肿瘤小组的III期临床随机试验的安全性分析HE 10/00
4. Results of treatment in patients with IIa - IIIast. breast cancer treated by combination of low-level laser therapy (LLLT) and surgery (5-year experience) [C] . V.A. Mikhailov, Ctr. of Laser Medicine, Moscow, CIS Selected Papers: Laser Use in Oncology . 1996

机译：IIa-IIIast患者的治疗结果。低水平激光疗法（LLLT）和手术相结合治疗乳腺癌（5年经验）
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Dose-dense sequential adjuvant chemotherapy followed as indicated by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial [O] . George Fountzilas, Urania Dafni, Christos Papadimitriou, 2014

机译：如所示在早期乳腺癌患者中进行了剂量密集的序贯辅助化疗随后是曲妥珠单抗治疗了一年：希腊合作肿瘤小组随机III期临床试验的5年中位随访首次报道
7. Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial [O] . Fountzilas, G., Dafni, U., Papadimitriou, C., 2014

机译：如所示，曲妥珠单抗在早期乳腺癌患者中接受剂量密集序贯辅助化疗一年：首次报告希腊合作肿瘤学组随机III期试验的5年中位随访

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

著录项

引文网络

相似文献

相关主题

期刊订阅